Given the high attrition rates, substantial costs and slow pace of new drug discovery and
development, repurposing of'old'drugs to treat both common and rare diseases is increasingly …

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are effective for obese patients with
type 2 diabetes mellitus (T2DM) because they concomitantly target obesity and dysglycaemia…

Among patients with tuberculosis, rifampin plasma concentrations and sputum conversion
rates have been reported to be lower in Africans. Rifampin is a substrate of P-glycoprotein (…

Background. Tenofovir (TFV) causes kidney tubular dysfunction (KTD) in some patients, but
the mechanism is poorly understood. Genetic variants in TFV transporters are implicated; we …

Aim: To conduct a pragmatic, randomized controlled trial to assess whether thiopurine
methyltransferase (TPMT) genotyping prior to azathioprine reduces adverse drug reactions (ADRs…

Although the prognosis of chronic myeloid leukemia (CML) patients treated with imatinib is
good, many fail to develop an optimal response or lose one. This heterogeneity could be …

Aims The aim of this study was to continually evaluate the association between cardiovascular
drug exposure and COVID‐19 clinical outcomes (susceptibility to infection, disease …

Background Nevirapine exhibits marked interpatient variability in pharmacokinetics.
CYP2B6 activity and demographic factors are important, but there are a few data on drug …

Aims: To update our previously reported systematic review and meta‐analysis of observational
studies on cardiovascular drug exposure and COVID‐19 clinical outcomes by focusing …

Background Darunavir is a potent protease inhibitor of HIV. To enhance its pharmacokinetic
profile, darunavir must be co-administered with ritonavir. There is wide inter-patient …